Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C23H21FN2O |
Molar mass | 360.432 g·mol−1 |
3D model (JSmol) | |
| |
|
THJ-2201 is an indazole-based synthetic cannabinoid that presumably acts as a potent agonist of the CB1 receptor and has been sold online as a designer drug.[1][2][3][4]
It is a structural analog of AM-2201 in which the central indole ring has been replaced by indazole.[5]